Celltrion today announced the U.S. launch of STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), following approval by the U.S. Food and Drug Administration (FDA) in December 2024.

His Highness Sheikh Khaled Bin Mohamed Bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive ...

The company raised Dh600 million ($163 million) through the issuance of 400 million shares, representing 40 per cent of its ...

This achievement marks a key step toward the partnership’s goal of deploying up to $2.5 billion by 2028, underscoring its ...

The German Foreign Office on Sunday condemned the recent outbreak of violence between Syria's new rulers and supporters of ...

Damage or injury to nerves causes a painful condition called neuropathy. This article reviews the safety and evidence behind ...

This manuscript addresses the role of alpha oscillations in sensory gain control. The authors use an attention-cuing task in an initial EEG study followed by a separate MEG replication study to ...

Wed, March 5, 2025 at 2:46 PM UTC Aliens Are Real, U.S. Government Officials Have Admitted. ‘The Age of Disclosure’ Director ...

Atmos's stock is currently unattractively priced for new investors, though I rate it a Hold for existing shareholders.

Angelina Jolie attended a brunch in Alabama to support her daughter Zahara, who spoke about period poverty. Zahara, a member ...

Frye Regional Medical Center was honored by Lifepoint Health with the organization’s Innovation Award at an annual awards ...

Lupus Pleurisy about a Case in the Pneumophthisiology Department of the Ignace Deen National Hospital of the Conakry ...